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Abstract
Background: Public health interventions are increasingly evaluated using cluster-randomised trials in which groups
rather than individuals are allocated randomly to treatment and control arms. Outcomes for individuals within the
same cluster are often more correlated than outcomes for individuals in different clusters. This needs to be taken
into account in sample size estimations for planned trials, but most estimates of intracluster correlation for
perinatal health outcomes come from hospital-based studies and may therefore not reflect outcomes in the
community. In this study we report estimates for perinatal health outcomes from community-based trials to help
researchers plan future evaluations.
Methods: We estimated the intracluster correlation and the coefficient of variation for a range of outcomes using
data from five community-based cluster randomised controlled trials in three low-income countries: India,
Bangladesh and Malawi. We also performed a simulation exercise to investigate the impact of cluster size and
number of clusters on the reliability of estimates of the coefficient of variation for rare outcomes.
Results: Estimates of intracluster correlation for mortality outcomes were lower than those for process outcomes,
with narrower confidence intervals throughout for trials with larger numbers of clusters. Estimates of intracluster
correlation for maternal mortality were particularly variable with large confidence intervals. Stratified randomisation
had the effect of reducing estimates of intracluster correlation. The simulation exercise showed that estimates of
intracluster correlation are much less reliable for rare outcomes such as maternal mortality. The size of the cluster
had a greater impact than the number of clusters on the reliability of estimates for rare outcomes.
Conclusions: The breadth of intracluster correlation estimates reported here in terms of outcomes and contexts
will help researchers plan future community-based public health interventions around maternal and newborn
health. Our study confirms previous work finding that estimates of intracluster correlation are associated with the
prevalence of the outcome of interest, the nature of the outcome of interest (mortality or behavioural) and the size
and number of clusters. Estimates of intracluster correlation for maternal mortality need to be treated with caution
and a range of estimates should be used in planning future trials.
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Public health interventions are increasingly evaluated
using cluster-randomised controlled trials (cRCTs) in
which groups rather than individuals are allocated ran-
domly to treatment and control arms. Cluster-randomised
designs are pertinent to public health for three main rea-
sons [1]. First, many contemporary public health interven-
tions are large in scale, complex in nature, and ‘unblinded’
in design because they require the active involvement of
participants. It is often more appropriate and feasible to
implement them ‘with’ groups or communities rather than
to apply them ‘to’ individuals. Second, cRCTs have the
advantage of minimising the risk of contamination that
would occur if individuals from the same community were
randomised to different treatment arms. Third, cRCTs
enable policy-makers and researchers to assess the popula-
tion-level effects of an intervention applied to a proportion
of a population, giving more information about its effec-
tiveness in real life settings. There are now numerous
examples of well-conducted public health cRCTs from
high, middle and low-income countries. The Mwanza
study, for example, tested the impact of improved sexually
transmitted infection (STI) case management on the inci-
dence of HIV infection in Mwanza, Tanzania, by rando-
mising 12 pair-matched communities to intervention or
control arms [2]. Other, current cRCTs include a UK
study in which deprived areas of London have been rando-
mised to receive interventions promoting healthy eating,
physical activity and mental health [3], and, in India, a trial
in which urban wards of Mumbai were randomly allocated
to a community mobilisation intervention for improved
maternal and newborn health [4].
An important implication of cluster-randomised
designs is that intervention recipients are often groups
of individuals who share socio-economic and cultural
characteristics and have similar health outcomes by vir-
tue of living in the same area. Similarity between indivi-
duals in the same cluster lessens the variability of
responses within clusters (within-cluster variance),
thereby artificially magnifying differences in outcomes
between clusters and reducing the power of trials to
detect true differences between intervention and control
arms. An intracluster correlation coefficient (ICC) is
commonly used to quantify how much more similar
outcomes are for individuals within clusters than for
those in different clusters [5,6]. The ICC is defined as
the ratio of the between-cluster variance to the total
variance (both between and within clusters), and there-
fore has a value between 0 and 1. An ICC of 0 indicates
that individuals within clusters are no more similar to
each other than individuals from different clusters (there
is no between-cluster variability), while an ICC of 1
indicates that individuals within the same cluster all
have identical outcomes (there is no within-cluster
variability) [1].
The increase in variance due to clustering, or design
effect, is given by 1 +( m-1) ICC, where m is the average
cluster size [7]. Within-cluster correlation has a corre-
late - between-cluster variation - which is commonly
expressed as the coefficient of variation, k. For binary
outcomes, the relationship between the ICC and k has
been defined as ICC = k2

π
1 − π

,w h e r eπ is the
probability of the binary outcome of interest [8].
Obtaining estimates of ICC or k is essential to calculate
sample sizes for studies with clustered designs, but these
are seldom available to researchers when designing trials
and are often approximated from previous research or
through modeling techniques [9-11].
Several community-based interventions to reduce
mortality in mothers and neonates in low-resource set-
tings have recently been evaluated through cRCTs, and
there is increasing momentum to support health sys-
tems in delivering components of these community pro-
grammes at scale [12-17]. Designing adequately powered
studies to measure the impact of programmes will be
critical. However, most ICC or k estimates for perinatal
health outcomes available in the literature come from
hospital-based studies and may therefore not reflect out-
comes in the community [18]. In this study, we report
ICC and k estimates for perinatal health outcomes from
community-based trials in three countries (Bangladesh,
India, and Malawi) to help researchers planning efficacy
and effectiveness evaluations of interventions to improve
maternal and newborn health.
Methods
We estimated ICC and k for a range of outcomes using
data from five community-based cRCTs, three of which
have not yet reported final results (MaiMwana and Mai-
Khanda in Malawi, and the City Initiative for Newborn
Health in India). All five trials sought to evaluate com-
munity mobilisation interventions with women’sg r o u p s
to improve maternal and newborn health outcomes. A
version of this intervention was first tested in Nepal,
where it achieved a 30% reduction in neonatal mortality
[18]. Figure 1 shows the location of the trials included
in the study. Table 1 describes their design, sample size,
and the number and characteristics of study clusters.
We report ICC and k for seven selected perinatal health
outcomes: neonatal mortality, stillbirths, maternal mortal-
ity, four or more antenatal care visits, skilled birth atten-
dance (by a nurse or doctor), exclusive breastfeeding prior
to interview at about six weeks, and postnatal check-ups
by a nurse or doctor in the same period. In addition, we
calculated ICC and k for uptake of HIV testing and use of
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are important outcomes for African studies. We selected
stillbirths and neonatal mortality because they are out-
comes commonly used to calculate perinatal study sample
sizes, maternal mortality because there are few reports of
ICC or k since it is a rare outcome, and other outcomes as
process indicators that may be increasingly used in the
future to calculate sample sizes for effectiveness studies.
We used the framework proposed by Campbell and collea-
gues [19] to report ICC and provide: a description of the
dataset from which estimates were drawn and a descrip-
tion of the outcome characteristics; information on how
ICC was calculated; and information on its precision
through a 95% confidence interval.
We chose to exclude data from the intervention clusters
of the five trials from the main calculations of ICC and k
for two reasons. First, three of the five trials had not yet
reported results for their primary outcome (neonatal mor-
tality) at the time of analysis. Second, we hypothesised that
the interventions tested in these studies could influence
ICC for perinatal outcomes, as they sought to increase
care-seeking and institutional deliveries. We felt that dis-
cussing the extent and reasons for variation between trial
intervention and control clusters was beyond the scope of
this paper and therefore opted to exclude data from the
trial intervention clusters. However, recent research under-
scores the importance of taking into account the likely
effect of the intervention when estimating the between-
cluster variability [20].
Data collection
In all five trials perinatal outcomes were measured using
community-based prospective surveillance systems [4].
These systems differed slightly between sites and are
briefly described here.
The Perinatal Care Project trial took place in three rural
districts of Bangladesh. In each district, six unions per dis-
trict (mean union population: 27 953) were purposively
sampled for surveillance. In these unions, Traditional
Birth Attendants (TBAs) prospectively reported births and
deaths to women in pregnancy or up to six weeks after
delivery within an area covering around 200 households.
Interviewers then verified the births and deaths, paid the
TBA an incentive for each correct identification, and com-
pleted a questionnaire covering maternal background
characteristics, the antenatal, delivery, and post-partum
periods with the mother, or, in case of a maternal death,
with a relative. All eligible women identified were also
asked if they could identify any other pregnant women.
In the Ekjut trial (Jharkhand & Orissa, rural eastern
India), a key informant, usually a community member,
covered around 250 households and prospectively
reported any births, maternal or newborn deaths and
deaths to women aged 15-49 within her allocated area.
The trial area covered 36 clusters over three districts
(mean cluster population 6338). Clusters were purposively
sampled to include a high proportion of tribal commu-
nities. In each district, 12 interviewers met with key infor-
mants, verified all births, and paid the key informant a fee
Figure 1 Location, population size and duration of studies.
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tered a structured questionnaire to mothers at around six
weeks after delivery to collect information about their
socio-demographic characteristics and events during the
antenatal, delivery and postnatal periods.
The City Initiative for Newborn Health in Mumbai
monitored 48 urban slum clusters of about 1000 house-
holds each (5500 population), selected randomly from a
sampling frame of 92 clusters over six municipal wards.
Births and deaths were identified by 99 locally resident
women, generally two per cluster, each covering an
average 500 households and receiving a fee for identifi-
cation. Events were confirmed by 12 interviewers, each
responsible for four clusters, who visited mothers at
home and arranged follow-up interviews.
In the MaiMwana trial (Malawi), pregnancies were
prospectively identifiedb yap a i dw o m a ne n u m e r a t o r
who visited all females aged 10-49 years once a month
to ask about missed menses. Information was recorded
in a register of all women of childbearing age and
updated monthly. Live births were followed up with
interviews one month and six months after birth [23].
There were 48 women enumerators (one per cluster),
and 48 interviewers (also one per cluster) who verified
births and conducted post-partum interviews.
In the MaiKhanda evaluation, also in Malawi, the team
selected health centre catchment areas with a typical
population of 30 000. Within each of these, a population
of 4000 was selected for surveillance by randomly
choosing catchment populations of government commu-
nity health workers that summed to roughly 4000. In
each of these areas, 20-25 key informants reported data
on births, deaths, and the antenatal and postnatal per-
iod. In all sites, verbal autopsies were conducted for
neonatal deaths, stillbirths, and maternal deaths.
Trial designs
The trials used moderately different designs to arrive at
one-to-one random allocation of intervention and con-
trol clusters. In the Perinatal Care Project (Bangladesh)
Table 1 Characteristics of studies used, prevalence, and rates, for key perinatal indicators from 5 community-based
cluster RCTs
Project
Country
Perinatal Care
Project
Rural
Bangladesh
Ekjut
Rural India
City Initiative
for Newborn
Health
Urban India
MaiMwana
Malawi
MaiKhanda*
Malawi
Study location Three districts:
Bogra,
Maulvibazaar
and Faridpur
Three districts of Jharkhand
and Orissa: Keonjhar, West
Singhbhum and Saraikela
Mumbai
municipality
Mchinji district Three districts: Lilongwe, Salima and
Kasungu
Period for which
data are included
1
st Feb 2005 -
31
st Dec 2007
1
st July 2005 - 30
th June
2008
1
st October
2005 - 30
th
September
2008
1
st January 2005 -
31
st January 2009
(study is ongoing)
1
st July 2008 - 31st July 2010 (study is
ongoing)
Estimated
population
478 000 228 000 280 000 180 000 312 000
Design Two-by-two
factorial cluster
RCT
Cluster RCT Cluster RCT Two-by-two
factorial cluster RCT
Two-by-two factorial cluster RCT
Stratification By district (3
strata)
By district (3 strata) By municipal
ward (6 strata)
None None
Cluster
characteristics
Villages making
up a union
8-10 village with residents
classified as tribal or OBC
1000-1500
households in
slum areas
Aggregated
villages and group
village headman
areas
Aggregated villages and group village
headman areas in the catchment area
of one Health Centre/Dispensary
Total number of
clusters (Number
included in this
study)**
18 (5) 36 (18) 48 (24) 48 (12) 76 (30)
Annual births per
cluster: Mean (SD)
587 (123) 171 (38) 131 (61) 139 (25) 143 (61)
Mean cluster
population (SD, min,
max)
27953 (5953,
15441-35110)
6338 (2101, 3605-7467) 5865 (1077,
4310-7750)
3958 (404, 3068-
4645)
3934 (1332, 2121-8558)
Crude birth rate*** 20.8 28.1 22.3 35.1 35.0
* MaiKhanda data are provisional as verification of deaths and follow-up of missing women are still ongoing.
**These are ‘pure’ control clusters. In the case of factorial designs, none of the interventions tested was being implemented in these clusters.
*** Number of live births per 1000 population during study period. We chose to use population estimates at the mid-point of trials as the denominator.
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and clusters purposively sampled, then randomised
within each district. In the Bangladesh Perinatal Care
Project, clusters initially randomised to the women’s
group interventions were also re-randomised to receive
training for Traditional Birth Attendants in a two-by-
two factorial design. In the Mumbai City Initiative for
Newborn Health trial, urban slum clusters were ran-
domly sampled from a frame stratified by six purpo-
sively selected municipal wards, and then randomly
allocated to the intervention. MaiKhanda and MaiM-
wana in Malawi used two-by-two factorial designs in
which clusters were allocated randomly to a women’s
group intervention or no intervention, and each group
was stratified by the presence or absence of another
intervention - a breastfeeding counseling intervention in
the case of MaiMwana, or a Quality Improvement of
maternal and neonatal facility-based healthcare interven-
tion in the case of MaiKhanda. For the Bangladesh Peri-
natal Care Project and the Malawi MaiKhanda and
MaiMwana trials, we therefore only included in this
study the clusters that were ‘pure’ controls. Details of
stratification and number of clusters included are given
in Table 1. Although all five trials included in the study
had baseline data, we only included these for the ‘pure’
control clusters of the MaiKhanda study in Malawi
because it started later than the other trials and had
fewer cases to contribute to the analysis. One of the
other trials (PCP) had retrospective baseline data, which
we decided not to include in order to preserve data
quality.
Ethical approval
All trials from which data for this study were drawn
were approved by the ethics committee of the Institute
of Child Health and Great Ormond Street Hospital for
Children (UK) and by the following research ethics
committees: the ethics committee of the Diabetic Asso-
ciation of Bangladesh (Perinatal Care Project, Bangla-
desh Diabetes Somity or BADAS); an independent
ethics committee in Jamshedpur, India (Ekjut trial); the
Mumbai Independent Ethics Committee for Research on
Human Subjects (City Initiative for Newborn Health
trial, reference IEC/06/31); the Malawi National Health
Sciences Research Committee (MaiMwana trial, refer-
ence MED/4/36/1/167, MaiKhanda protocol #420). All
trials were conducted in disadvantaged areas with high
levels of female illiteracy; all participants gave consent in
writing, by thumbprint or verbally.
Outcome definitions
We used the ICD 10 definitions of neonatal death, still-
birth and maternal death [24]:
Stillbirth - “A stillbirth or foetal death is a death
prior to the complete expulsion or extraction from its
mother of a product of conception, irrespective of the
duration of pregnancy; the death is indicated by the
fact that after such separation the foetus does not
breathe or show any other evidence of life, such as
beating of the heart, pulsation of the umbilical cord
or definite movement of voluntary muscles.” ICD
classifies late foetal deaths (birthweight greater than
1000 gm or after 28 weeks) and early foetal deaths
(500 to 1000 gm or 22-28 weeks). We use the ICD-10
criteria for stillbirth modified to include births after
28 completed weeks rather than 22 weeks.
Neonatal death: death within the first 28 days of an
infant after “the complete expulsion or extraction
from its mother of a product of conception, irrespec-
tive of the duration of the pregnancy, which after
such separation, breathes or shows any other evi-
dence of life, such as beating of the heart, pulsation
of the umbilical cord, or definite movement of
voluntary muscles, whether or not the umbilical
cord has been cut or the placenta is attached.”
Maternal death: “the death of a woman while preg-
nant or within 42 days of termination of pregnancy,
irrespective of the duration and site of the preg-
nancy, from any cause related to or aggravated by
the pregnancy or its management but not from acci-
dental or incidental causes.”
For postnatal outcomes (exclusive breastfeeding and
postnatal check-up by a doctor or a nurse), we used
data collected between one month and six weeks after
birth, except in MaiMwana Malawi where data were
available on exclusive breastfeeding up to six months.
Statistical analysis and calculations
We used two methods for estimating ICC: one-way ana-
lyses of variance in STATA (Versions 10 and 11; Stata
Corp., College Station, TX) using the loneway command
as described by Hayes and Moulton [1], and estimation
equations from Donner and Klar [25], p84-5. We calcu-
lated estimates and confidence intervals for ICC within
each stratum, then calculated the unweighted average of
the ICC estimates and the lower and upper bounds of
the confidence intervals across strata. For the ICC esti-
mates calculated using Donner and Klar’s equations, we
calculated 95% confidence intervals using Fisher’s
method [26], which uses the following equation:
ICC ± 1.96

V(ICC) where
V(ICC)=
2(1 − ICC)
2
1+( m − 1)ICC
2
m(m − 1)n
where m is
the mean number of births per cluster and n is the
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mate for the lower bound of the confidence interval for
ICC was negative, we set it to zero, assuming that the
population within our clusters would not be more het-
erogeneous than the entire study population.
For all outcomes, we calculated k from the intracluster
correlation coefficients by reversing the equation from
Hayes and Moulton [1]: k =
  
	
ICC ×


1 −
  π

ˆ π
,w h e r eI C C
is the estimated intracluster correlation coefficient and
ˆ π is the observed proportion of the binary outcome for
the entire population.
Several practical issues arose when calculating ICC
using individual-level datasets in which the denomina-
tors were births. For example, we recoded the vital sta-
tus for mothers who died but had twins so that
maternal deaths were not double-counted. In addition,
calculating ICC for maternal mortality (where live births
are the denominator) required adding antepartum
deaths to the list of live births so that they could be
counted.
Simulation experiments
In order to explore further the impact of cluster size
and number on the reliability of estimates of k,w er a n
two simple simulations for maternal and neonatal mor-
tality in Microsoft Excel 2003 (Microsoft Corporation).
In each simulation we considered a hypothetical study
area with a given number of clusters and a given num-
ber of live births per cluster. We set the maternal mor-
tality ratio (MMR) at 300 deaths per 100 000 live
births and the neonatal mortality rate (NMR) at 40
deaths per 1000 live births. For each run of the simula-
tion, we randomly assigned neonatal and maternal out-
comes for each cluster by generating random numbers
and assigning outcomes according to the assumed
mortality rates. By doing this, we made an explicit
assumption that the outcomes of births were indepen-
dent of the outcomes of other births, so that the coef-
ficient of variation, k, for each simulation was identical
to zero (individuals within clusters were set to be no
more similar to each other than to individuals from
different clusters). Each run of the simulation thus
generated a hypothetical set of maternal and neonatal
outcomes, from which we calculated the coefficient of
variation k that would be estimated if these were real
data, using the formula described by Hayes and Moul-
ton [1, p.18]. The impact of cluster size and number of
clusters is evaluated by comparing estimates of k to
the ‘true’ k of zero: the smaller the estimates and the
narrower their range across simulations, the more reli-
able the estimates.
Results
Prevalence and rates for selected perinatal indicators
Table 2 shows the mortality rates or outcome preva-
lence for our selected perinatal indicators within the five
community-based samples, as well as corresponding
estimates of ICC and k. We observed substantial differ-
ences in maternal and neonatal mortality rates between
the study sites: the rural Indian setting (Ekjut trial,
Jharkhand and Orissa) had the highest maternal and
neonatal mortality rates, while the urban Indian setting
(City Initiative for Newborn Health, Mumbai) had the
lowest. In some cases, we found large differences
between our community-based mortality estimates and
national Demographic and Health Survey (DHS) figures.
In eastern India, among rural tribal communities, the
NMR was 59.1, compared with 39 per 1000 reported as
the state estimate for Jharkhand in the 2007 National
Family Health Survey [27]. In both Malawian studies we
found lower maternal mortality rates than the most
recently reported DHS figure of 984 per 100 000 [28].
These differences may reflect national and regional dif-
ferences, different sample compositions, different time
frames or methodological factors. We also found differ-
ences in key antenatal and care-seeking indicators
between the study sites. Access to four antenatal care
visits was low in all sites except Mumbai, reflecting
greater access to private and public health services in
urban areas. The prevalence of skilled birth attendance
among mothers in Mumbai slums was four times that
among mothers in eastern Indian tribal communities,
and was much higher in rural Malawian than rural
Asian settings.
Intracluster correlation coefficients for selected perinatal
indicators
Overall, ICCs for mortality outcomes were lower than
for process outcomes such as skilled birth attendance
(SBA). Estimates of intracluster correlation for MMR
and NMR were low in all sites. Estimates for maternal
mortality were particularly unreliable, reflected in the
broader confidence intervals, with a single maternal
death having large impacts on ICC and k values. We
noted that the ICCs estimated using the loneway com-
mand (one-way analysis of variance) in STATA were
very similar to those calculated using the equations of
Donner and Klar, especially for the more common out-
comes of neonatal death and stillbirth.
ICCs for behavioural outcomes such as care-seeking
were higher than those for mortality outcomes, not only
because the proportions of interest were higher, but also
perhaps because one might expect them to be more simi-
lar for women living in the same area than for women in
other areas. It is also possible that cluster-specific
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Page 6 of 12Table 2 Intracluster correlation coefficients and coefficients of variation for key perinatal indicators
Project
Country
Perinatal Care Project
Rural Bangladesh
Ekjut
Rural India
City Initiative for Newborn Health
Urban India
MaiMwana
Malawi
MaiKhanda*
Malawi
Neonatal mortality
Neonatal deaths 314 518 127 187 357
Live births 8503 8819 8283 6688 12499
Neonatal deaths, % of
live births
3.7 5.9 1.5 2.8 2.9
Neonatal mortality
rate, per 1000 live
births
37.0 58.7 15.3 28.0 28.6
Stata-one way ICC
stratum-averaged
(95% CI)
0.00055
(0-0.00316)
0.00099
(0-0.00591)
- 0.00247
(0-0.00605)
0.00034
(0-0.00346)
Stata-one way k 0.15 0.13 - 0.29 0.15
Donner and Klar ICC
(95% CI)
0.00055
(0-0.0024)
0.00099
(0-0.00442)
0.0004
(0-0.0041)
0.00309
(0-0.0070)
0.00094
(0-0.00263)
Donner and Klar k 0.12 0.13 0.16 0.33 0.18
Stillbirths
Stillbirths 298 270 106 116 406
Births 8801 9089 9719 6804 12905
Stillbirths, % of births 3.4 3.0 1.1 1.7 3.1
Stillbirth rate, per
1000 births
33.9 29.7 10.9 17.0 31.5
Stata-one way
stratum-averaged ICC
(95% CI)
0.00000
(0-0.00224)
0.00012
(0-0.00307)
- 0.00000
(0-0.00148)
0.00206
(0-0.00590)
Stata one way k 0.00 0.06 - 0.00 0.25
Donner and Klar ICC
(95% CI)
0.00000
(0-0.00062)
0.00012
(0-0.00250)
0.0013
(0-0.0055)
0.000
(0-0.0015)
0.00242
(0.00002-0.00482)
Donner and Klar k 0 0.06 0.34 0.00 0.27
Maternal mortality
Maternal deaths 19 68 21 32 42
Livebirths 8503 8819 8283 6710 12499
Maternal deaths, % of
live births
0.22 0.77 0.25 0.48 0.33
Maternal mortality
ratio, per 100 000
livebirths
223.4 771.1 219.8 476.9 336
Stata-one way ICC
(95% CI)
0.00008
(0-0.00014)
0.00051
(0-0.00382)
- 0.00000
(0-0.00150)
0.00031
(0, 0.00172)
Stata-one way k 0.19 0.26 - 0.00 0.10
Donner and Klar ICC
(95% CI)
0.00005
(0-0.00082)
0.00071
(0-0.00383)
0.0034
(0-0.010)
0.000
(0-0.0015)
0.00333
(0.00044-0.00622)
Donner and Klar k 0.16 0.30 1.16 0.00 0.99
Four antenatal
check-ups (ANC)
Mother received 4 or
more ANC check-ups
%, (N)
15.1%
(8189)
23.4%
(8867)
84.2%
(7834)
26.6% (6436) Not collected
Stratum-averaged ICC
(95% CI)
0.04849
(0-0.18522)
0.15444
(0.30298-0.31837)
0.0211
(0-0.06073)
0.03010
(0.00398-0.05623)
-
K 0.52 0.71 0.06 0.29 -
Skilled birth
attendance
Births attended by a
nurse or doctor % (N)
15.2%
(8801)
23.3%
(9089)
87%
(7834)
41.9%
(6788)
52.9%
(12853)
Stratum-averaged ICC
(95% CI)
0.03233
(0.00831-0.00319)
0.04103
(0.00594-0.14733)
0.02522
(0-0.07051)
0.15243
(0.04186-0.26300)
0.12699
(0.06411, 0.18926)
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Page 7 of 12features (for example, the presence of a popular health
facility) could influence the proportion of outcomes such
as skilled birth attendance in each cluster, and thereby
ICC and k.
It is likely that there were genuine differences in
population heterogeneity across sites. For instance,
urban slums are home to a range of communities that
maintain to some degree patterns of behaviour imported
from their places of origin; they also maintain their
rural-urban links. Urban areas might therefore be
expected to be more heterogeneous than rural villages.
Equally, there might be cultural factors that lead women
to care for their infants more or less similarly in differ-
ent countries.
Areas with smaller cluster sizes tended to yield higher
ICCs. In the MaiKhanda study in Malawi, the average
cluster size in Lilongwe was about three-quarters that of
the other two districts, an dt h eI C Cf o rL i l o n g w ew a s
h i g h e r .N o ts u r p r i s i n g l y ,e stimates drawn from larger
numbers of clusters were more reliable (narrower
confidence intervals) than those from small numbers. Esti-
mates drawn from the Bangladesh Perinatal Care Project
varied widely between districts and overall estimates
appeared to have more face validity than district-specific
data, which yielded more extreme values. This was espe-
cially the case for the maternal mortality estimates. Strati-
fication reduced ICC as well as k values, but had a greater
impact on ICCs. For instance, in the rural India trial, the
estimate for ICC based on the average of estimates for
ICC in each stratum for stillbirths was 0.00012, compared
with 0.00033 when stratification was ignored.
Measuring ICCs for rare outcomes: simulation results
Neonatal and maternal deaths are relatively rare popula-
tion events. A typical MMR in a low-income setting
might be around 300 per 100 000 live births. If the total
number of live births per cluster over the period of a
trial is 400 to 2000, there will, on average, only be
between 1 and 6 deaths per cluster. Given such small
numbers, we would expect much variation in the actual
Table 2 Intracluster correlation coefficients and coefficients of variation for key perinatal indicators (Continued)
K 0.42 0.36 0.06 0.46 0.34
Postnatal check-up
Infants received a
postnatal check-up %
(N)
20.9%
(8128)
6.3%
(8301)
56.5%
(7711)
30.9%
(5949)
-
Stratum-averaged ICC
(95% CI)
0.03558
(0-0.12604)
0.01873
(0-0.05687)
0.01566
(0-0.04627)
0.23066
(0.07948-0.38185)
-
K 0.36 0.52 0.11 0.72 -
Exclusive
breastfeeding (1
st 6
weeks)
Infants exclusively
breastfed for the first
6 weeks % (N)
62.6%
(8128)
62.3%
(8301)
64.7%
(7711)
9.2%
(3749)**
-
Stratum-averaged ICC
(95% CI)
0.01286
(0-0.04821)
0.09163
(0.0006-0.23459)
0.01341
(0-0.04062)
0.03746
(0.00351-0.07140)
-
K 0.08 0.23 0.09 0.61 -
Uptake of antenatal
HIV testing
Uptake of HIV testing
% (N)
- - - 39.2%
(6624)
-
ICC (95% CI) - - - 0.05457
(0.00950-0.09964)
-
K - - - 0.29 -
Use of insecticide-
treated bednets
during pregnancy
Use of insecticide-
treated bednets & (N)
- - - 48.1% (6678) -
ICC (95% CI) - - 0.06059
(0.01105-0.11013)
-
K - - 0.26 -
ICC: intracluster correlation coefficient; k: coefficient of variation.
* MaiKhanda data are provisional as verification of deaths and follow-up of missing women are still ongoing.
** MaiMwana collected data on exclusive breastfeeding for the first 6 months of life.
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quently, significant random variation in estimates of
intracluster correlation. This is shown with our estimate
of ICCs for observed maternal mortality in Table 2.
We ran two simulations in order to explore the impact
of different numbers of live births per cluster (simulation
1) and of the number of clusters (simulation 2) on esti-
mated k for maternal and neonatal mortality. Results are
shown in table 3 and summarised for k in figures 2 and 3.
In simulation 1 the MMR was fixed at 300, the NMR at
40 and the number of clusters at 32. We performed sets
of 500 simulation runs, each set of runs corresponding to
different numbers of live births per cluster, and calcu-
lated the mean and 75th percentile of the estimated k for
maternal and neonatal death. In simulation 2 the number
of clusters was varied. The MMR was fixed at 300, the
NMR at 40 and the number of births per cluster at 400.
Since the true value of k was zero, the results help us to
understand the impact of cluster size and number of
clusters on the reliability and stability of our measured
point estimates for both maternal and neonatal mortality.
Figures 2 and 3 show that estimates of k are much less
reliable when the number of births per cluster is less
than 500 for both maternal and neonatal outcomes. The
number of clusters was less important in determining
the reliability of estimates of k for neonatal mortality,
but for maternal mortality fewer than 60 clusters led to
less reliable estimates of k. Across all simulations,
Table 3 Simulation results showing the impact of number of live births per cluster and number of clusters on k
estimates for rare outcomes
Live births
per cluster
Simulation mean k for
maternal mortality
75
th percentile of estimated k
for maternal mortality
Simulation mean k for
neonatal mortality
75th percentile of estimated k
for neonatal mortality
200 0.23 0.44 0.070 0.14
400 0.19 0.37 0.045 0.090
800 0.12 0.26 0.034 0.071
1600 0.10 0.20 0.021 0.042
3200 0.06 0.13 0.018 0.036
Clusters
16 0.23 0.42 0.059 0.12
32 0.18 0.37 0.047 0.092
64 0.15 0.28 0.040 0.084
128 0.15 0.28 0.035 0.072
Mean estimated 
coefficient of variation k
Figure 2 Simulated impact of number of live births per cluster
on estimated coefficient of variation (k) for maternal and
neonatal mortality. These simulations were run assuming that all
birth outcomes were independent, i.e. the true coefficient of
variation was set to zero. As the number of births per cluster
increases, the estimated coefficient of variation falls closer to zero
indicating that more births per cluster lead to greater reliability in
estimates of the coefficient of variation. Throughout, the estimated
coefficient of variation is higher for maternal mortality than for
neonatal mortality.
Mean estimated 
coefficient of variation k
Figure 3 Simulated impact of number of clusters on estimated
coefficient of variation (k) for maternal and neonatal mortality.
These simulations were run assuming that all birth outcomes were
independent, i.e. the true coefficient of variation was set to zero. As
the number of clusters increases, the estimated coefficient of
variation falls closer to zero indicating that more clusters lead to
greater reliability in estimates of the coefficient of variation.
Throughout, the estimated coefficient of variation is higher for
maternal mortality than for neonatal mortality. In comparison with
figure 2, the number of births per cluster has a greater impact on
estimates of coefficient of variation than the number of clusters.
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reliable than for neonatal mortality. Considering the
75
th percentile of estimates in table 3, 25% of simulation
runs for maternal mortality resulted in high estimates of
k (> 0.25), even with 800 births per cluster in simulation
1 and across all numbers of clusters in simulation 2.
Estimates of k for neonatal mortality had a smaller
range throughout.
Discussion
Data from our trials accord with the rare published ICCs
for perinatal outcomes from other community-based stu-
dies. A recent systematic review of community-based
interventions to reduce maternal mortality found five
cluster-randomised controlled trials seeking to improve
perinatal survival [29]. None of these adjusted for cluster
effect on maternal mortality and the ICC for maternal
mortality was estimated to be close to 0.
For neonatal mortality, the Newhints trial in Ghana
reported a baseline ICC of 0.0007256 (with a baseline
neonatal mortality rate of 31 per 1000 livebirths) [30],
and the Makwanpur Nepal cRCT an ICC of 0.00644
(95% CI 0.00004-0.0128) [5]. By contrast, estimates from
our community-based samples were generally lower
than those reported in an analysis of ICCs for perinatal
outcomes in hospitals conducted as part of the 2005
WHO Survey on Maternal and Perinatal Health using
data from over 90 000 births in 120 facilities across
eight Latin American countries. Although the compar-
ability of data from the WHO survey and ours is com-
promised by differences in data collection and outcome
ascertainment methods, it is worth noting that the med-
ian ICC for neonatal death at hospital discharge or 7
days after delivery was 0.005, and the median ICC for
maternal death was 0.003 in the WHO study, while our
one-way analysis of variance ICC estimates range from
0.00034 to 0.00247 for neonatal death and from 0 to
0.00051 for maternal death. The higher ICCs found in
the WHO study may reflect greater similarities in out-
comes and practices among women who deliver in insti-
tutions, as well as differences inherent to the Latin
American context.
Previous studies have suggested that the research set-
ting (for example, primary or secondary care) and the
type of variable (process or outcome) are key determi-
nants of ICCs, but that the effects of outcome preva-
lence and cluster size are less straightforward [31]. Our
study confirms the first two findings, but also suggests,
as simulation work shows, that cluster size and the
number of clusters also affect estimates of ICCs (or k).
The simulation results highlight the difficulty in inter-
preting estimates of intracluster variability for rare out-
comes such as maternal mortality. In almost all the
simulation runs 25% of estimates of k for maternal
mortality were greater than 0.25. Given that in these
simulations there was no intracluster correlation, such
estimates would have been misleading if derived from
an actual data set. Given the wide range of maternal
mortality estimates of k over the sets of 500 simulation
runs, we must be cautious in placing too much trust in
estimates of k (or ICC) for maternal mortality from indi-
vidual trials, including our estimates given in table 2.
However, the simulation experiments show much lower
estimates of k for neonatal mortality with a much nar-
rower range, indicating that estimates for NMR from
individual trials are likely to be reliable, even with small
numbers of clusters or births per cluster.
Limitations
Our study had three main limitations. First, we drew
upon heterogeneous trials with different cluster recruit-
ment strategies and degrees of stratification. These
design features need to be taken into consideration
when using our ICCs to calculate sample sizes. For
example, increased stratification leads to lower ICCs and
k values. Second, ICCs could have been influenced by
different reporting preferences in different clusters. For
example, some cluster-based key informants or inter-
viewers might have been more adept at reporting or
tracking births and deaths than others. Quality of data
collection (in terms of both completeness and accuracy)
will strongly influence ICCs and is likely to vary
between clusters given differences in fieldworkers, ter-
rain and supervision. Finally, we used data from trials
with fewer than 40 clusters in their control arms. Don-
ner and Klar advise against overestimating the stability
of a sample estimate obtained from a trial involving less
than about 40 clusters. The small number of clusters
selected would also have increased the confidence inter-
vals around our ICC estimates. We also note that Fish-
er’s method for estimating confidence intervals is
unlikely to be strictly valid for the smaller samples used
in this study. However, combined, our study offers the
largest number of ICCs available to date for perinatal
outcomes for community-based samples.
Conclusions
Our study has three main implications. The first relates
to the importance of using data drawn from community-
based samples when planning effectiveness studies. Mor-
tality estimates from our community-based trials were
often substantially different from national DHS estimates
and ICCs from our community-based samples in Asia
and Africa were lower than those estimated from hospi-
tal-based samples in Latin America. This underscores the
importance of collecting baseline data to obtain adequate
estimates of mortality when planning evaluations of com-
munity interventions. Second, our results accord with
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the key determinants of the intracluster correlation coef-
ficient: the size of the ICC is related to the prevalence of
the outcome of interest, and point estimates of ICC for
rare outcomes such as maternal mortality are not likely
to be reliable. When planning future trials, published
estimates of ICCs from larger clusters are probably safer
to use and a range of possible ICCs should be used for
sample size calculations. Finally, as maternal and neona-
tal survival increases and research moves to testing inter-
ventions seeking to improve care-seeking or process
outcomes, the high ICCs found for these will need to be
accounted for in study sample sizes.
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